[HM-PAO cerebral blood flow scintigraphy in the manifestation stage of brain death].
We monitored 27 patients with HM-PAO-perfusion scintigraphy during the progress of cerebral death. The results of scintigraphy correlate well with cerebral angiography. Advantages are the possibility of bedside-examination, the non-invasiveness of the method and the possibility of in-vivo control. The non-visualized-brain in dynamic scintigraphy is a valuable additional method in the determination and documentation of cerebral death.
Berlit
P
P
Neurologische Klinik, Universität Heidelberg.
Wetzel
E
E
D000293:Adolescent; D000328:Adult; D000368:Aged; D001783:Blood Flow Velocity / Q000502:physiology; D001921:Brain / Q000098:blood supply*; D001926:Brain Death / Q000000981:diagnostic imaging*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D015609:Organotechnetium Compounds; D010091:Oximes; D011877:Radionuclide Imaging; D012039:Regional Blood Flow / Q000502:physiology; D012151:Resuscitation; D019690:Technetium Tc 99m Exametazime
D015609:Organotechnetium Compounds; D010091:Oximes; D019690:Technetium Tc 99m Exametazime
HM-PAO-Hirnblutflussszintigraphie in der Manifestationsphase des Hirntodes.